Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- WHO's big health update: Global life expectancy nearly back to pre-COVID levels
- Chewing tobacco linked to 2.51 lakh deaths globally in 2023, finds study
- Think insomnia is harmless? New research reveals serious health risks
- No need for fast running: Just 10 minutes at walking pace may boost brain function, finds study
- Can eating with your partner help control blood sugar? Study says yes
-1791127926.jpg "Image of the day: October 4, 2026")
